{"url":"https://lda.senate.gov/api/v1/filings/8f507a30-5ea1-4ba6-96d2-e6da484a4337/","filing_uuid":"8f507a30-5ea1-4ba6-96d2-e6da484a4337","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2021,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/8f507a30-5ea1-4ba6-96d2-e6da484a4337/print/","filing_document_content_type":"text/html","income":"10000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Elizabeth Duthie","dt_posted":"2022-04-13T15:24:07-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"7 Jerome Smith Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Ocean","registrant_state":"NJ","registrant_zip":"07712","registrant":{"id":400779345,"url":"https://lda.senate.gov/api/v1/registrants/400779345/","house_registrant_id":41737,"name":"JUNTO SOLUTIONS, LLC","description":"Public Affairs","address_1":"7 Jerome Smith Drive","address_2":null,"address_3":null,"address_4":null,"city":"Ocean","state":"NJ","state_display":"New Jersey","zip":"07712","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ELIZABETH DUTHIE","contact_telephone":"+1 609-902-0398","dt_updated":"2023-09-19T15:25:20.283273-04:00"},"client":{"id":212399,"url":"https://lda.senate.gov/api/v1/clients/212399/","client_id":24,"name":"WE WORK FOR HEALTH","general_description":"Biopharmaceutical advocacy and educational outreach","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-07-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Non-interference, Prescription Drug Pricing, Medicare Parts B and D, Patient Access and Innovation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":56787,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DUTHIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Non-interference, Prescription Drug Pricing, Medicare Parts B and D, Patient Access and Innovation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":56787,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DUTHIE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}